These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11026816)
1. [Allogenic bone marrow transplantation complications. Part II]. Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816 [TBL] [Abstract][Full Text] [Related]
2. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation. Aranha FJ; Vigorito AC; De Sousa CA; Oliveira GB; Zulli R; Lorand-Metze I Haematologica; 2002 Feb; 87(2):219-20. PubMed ID: 11836174 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666 [TBL] [Abstract][Full Text] [Related]
4. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472 [No Abstract] [Full Text] [Related]
6. Pulmonary complications following bone marrow transplantation. Chan CK; Hyland RH; Hutcheon MA Clin Chest Med; 1990 Jun; 11(2):323-32. PubMed ID: 2189666 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Araten DJ; Luzzatto L Haematologica; 2000 Jan; 85(1):1-2. PubMed ID: 10627666 [No Abstract] [Full Text] [Related]
8. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Auletta JJ; Cooke KR Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239 [TBL] [Abstract][Full Text] [Related]
9. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A; Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791 [TBL] [Abstract][Full Text] [Related]
10. [Roles of clinical laboratory monitoring in bone marrow and peripheral blood stem cell transplantation]. Hino M; Yamane T; Ohta K; Nakaie K; Kubota H; Fujino K; Takubo T; Tatsumi N Rinsho Byori; 2001 Jul; 49(7):657-61. PubMed ID: 11519125 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient. Marco de F; Infante B; Giovanni S; Gesualdo L Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371 [No Abstract] [Full Text] [Related]
13. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844 [TBL] [Abstract][Full Text] [Related]
14. Is there an effective therapy for chronic graft-versus-host disease? Schiller G; Gale RP Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281 [No Abstract] [Full Text] [Related]
15. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation. Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778 [TBL] [Abstract][Full Text] [Related]
16. The potential utility of statins as novel weapons against graft-versus-host disease. Namazi MR; Handjani F; Sodaifi M Med Hypotheses; 2005; 65(6):1203-4. PubMed ID: 16139438 [No Abstract] [Full Text] [Related]
17. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation]. Basić-Jukić N; Labar B Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection after bone marrow transplantation in children. Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440 [TBL] [Abstract][Full Text] [Related]
19. [Indication of bone marrow transplantation]. Masaoka T Rinsho Byori; 1995 Jul; Suppl 99():1-7. PubMed ID: 7474413 [No Abstract] [Full Text] [Related]
20. Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease. Kumar S; Wolf RC; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR Bone Marrow Transplant; 2002 Aug; 30(3):161-5. PubMed ID: 12189534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]